Skip to main content

Winssinger Frederic J's Form 4 filing

Usana Health Sciences Inc (USNA) · filed Aug 18, 2023

Accession no.
0001415889-23-012400
Filed
Aug 18, 2023
Trade date
Aug 17, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $59.4K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Winssinger Frederic JCIK 0001673356Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 17, 2023Common StockSSaleDisposed−930$63.84F1−$59,371.21,703Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Weighted average price $63.8411. Price range in multiple transactions was $63.7949 to $63.865 inclusively.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)